Literature DB >> 17059372

Torg syndrome is caused by inactivating mutations in MMP2 and is allelic to NAO and Winchester syndrome.

Andreas Zankl1, Lauren Pachman, Andrew Poznanski, Luisa Bonafé, Fengqiang Wang, Yelena Shusterman, David A Fishman, Andrea Superti-Furga.   

Abstract

UNLABELLED: Torg syndrome is a multicentric osteolysis syndrome of unknown etiology. We identified mutations in the MMP2 gene in a patient with Torg syndrome that resulted in complete loss of MMP2 activity. MMP2 mutations were previously identified in patients with NAO and Winchester syndrome. Our findings suggest that Torg, NAO, and Winchester syndrome are allelic disorders.
INTRODUCTION: Torg, nodulosis-arthropathy-osteolysis (NAO), and Winchester syndrome are a group of autosomal recessive osteolysis syndromes with marked clinical and radiological overlap. It has been suggested that the three conditions are causally related, but molecular evidence for this assumption has been lacking. Recently, mutations in the matrix metalloproteinase 2 gene (MMP2) have been reported in patients with NAO and Winchester syndrome.
MATERIALS AND METHODS: We sequenced the MMP2 gene in a patient with clinical and radiographic findings of Torg syndrome. MMP2 activity was measured with gelatin zymography.
RESULTS: Two mutations in the MMP2 gene were identified in this patient. Gelatin zymography indicated complete loss of MMP2 activity.
CONCLUSIONS: Torg, NAO, and Winchester syndrome are allelic disorders. The name Torg-Winchester syndrome is suggested as a common denominator for this group of disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17059372     DOI: 10.1359/jbmr.061013

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  20 in total

1.  Multicentric carpotarsal osteolysis is caused by mutations clustering in the amino-terminal transcriptional activation domain of MAFB.

Authors:  Andreas Zankl; Emma L Duncan; Paul J Leo; Graeme R Clark; Evgeny A Glazov; Marie-Claude Addor; Troels Herlin; Chong Ae Kim; Bruno P Leheup; Jim McGill; Steven McTaggart; Stephan Mittas; Anna L Mitchell; Geert R Mortier; Stephen P Robertson; Marie Schroeder; Paulien Terhal; Matthew A Brown
Journal:  Am J Hum Genet       Date:  2012-03-01       Impact factor: 11.025

2.  Winchester syndrome: the progression of radiological findings over a 23-year period.

Authors:  Radovan Vanatka; Cécile Rouzier; Jean Claude Lambert; Carole Leroux; Alain Coussement
Journal:  Skeletal Radiol       Date:  2010-09-24       Impact factor: 2.199

3.  Functional characterisation of a novel mutation affecting the catalytic domain of MMP2 in siblings with multicentric osteolysis, nodulosis and arthropathy.

Authors:  Jacopo Azzollini; Davide Rovina; Cristina Gervasini; Ilaria Parenti; Alessia Fratoni; Maria Vittoria Cubellis; Amilcare Cerri; Luca Pietrogrande; Lidia Larizza
Journal:  J Hum Genet       Date:  2014-10-02       Impact factor: 3.172

4.  Terminal osseous dysplasia with pigmentary defects (TODPD): Follow-up of the first reported family, characterization of the radiological phenotype, and refinement of the linkage region.

Authors:  Nicola Brunetti-Pierri; Ralph Lachman; Kwanghyuk Lee; Suzanne M Leal; Pasquale Piccolo; Ignatia B Van Den Veyver; Carlos A Bacino
Journal:  Am J Med Genet A       Date:  2010-07       Impact factor: 2.802

5.  Detection of gelatinolytic activity in developing basement membranes of the mouse embryo head by combining sensitive in situ zymography with immunolabeling.

Authors:  Nikolaos Gkantidis; Christos Katsaros; Matthias Chiquet
Journal:  Histochem Cell Biol       Date:  2012-06-12       Impact factor: 4.304

Review 6.  Multicentric osteolysis with nodulosis and arthropathy (MONA) with cardiac malformation, mimicking polyarticular juvenile idiopathic arthritis: case report and literature review.

Authors:  Filip Christian Castberg; Susanne Kjaergaard; Rebecca A Mosig; Mollie Lobl; Chiara Martignetti; John A Martignetti; Charlotte Myrup; Marek Zak
Journal:  Eur J Pediatr       Date:  2013-07-31       Impact factor: 3.183

7.  A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects.

Authors:  Beyhan Tuysuz; Rebecca Mosig; Gürkan Altun; Selim Sancak; Marc J Glucksman; John A Martignetti
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

8.  Clinical and radiographic findings in two brothers affected with a novel mutation in matrix metalloproteinase 2 gene.

Authors:  Faysal Gok; Lauréane Mittaz Crettol; Yasemin Alanay; Bulent Hacihamdioglu; Murat Kocaoglu; Luisa Bonafe; Seza Ozen
Journal:  Eur J Pediatr       Date:  2009-08-04       Impact factor: 3.183

9.  Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.

Authors:  Mikala Egeblad; H-C Jennifer Shen; Danielle J Behonick; Lisa Wilmes; Alexandra Eichten; Lidiya V Korets; Farrah Kheradmand; Zena Werb; Lisa M Coussens
Journal:  Dev Dyn       Date:  2007-06       Impact factor: 3.780

10.  Taurodontism in dental genetics.

Authors:  Manogari Chetty; Imaan A Roomaney; Peter Beighton
Journal:  BDJ Open       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.